Gratus Wealth Advisors LLC Cuts Position in Danaher Corporation $DHR

Gratus Wealth Advisors LLC decreased its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,687 shares of the conglomerate’s stock after selling 64 shares during the period. Gratus Wealth Advisors LLC’s holdings in Danaher were worth $531,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. GHP Investment Advisors Inc. raised its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC increased its stake in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher in the first quarter worth about $31,000. Dunhill Financial LLC lifted its stake in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after buying an additional 67 shares in the last quarter. Finally, Costello Asset Management INC purchased a new stake in shares of Danaher during the first quarter valued at approximately $41,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 2.2%

Danaher stock opened at $215.05 on Monday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a market cap of $153.98 billion, a P/E ratio of 45.75, a P/E/G ratio of 3.06 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The business has a 50-day simple moving average of $200.19 and a two-hundred day simple moving average of $197.24.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period last year, the firm earned $1.72 earnings per share. The company’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is presently 27.23%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DHR. Robert W. Baird boosted their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Bank of America reduced their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Barclays reaffirmed an “overweight” rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Finally, UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $245.91.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.